Safety and efficacy of repeat radiosurgery for acromegaly: an International Multi-Institutional Study
- 20 September 2019
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 145 (2) , 301-307
Abstract
Surgical resection is the first line treatment for growth hormone (GH) secreting tumors. Stereotactic radiosurgery (SRS) is recommended for patients who do not achieve endocrine remission after resection. The purpose of this study was to evaluate safety and efficacy of repeat radiosurgery for acromegaly.Keywords
This publication has 31 references indexed in Scilit:
- Repeat stereotactic radiosurgery for Cushing’s disease: outcomes of an international, multicenter studyJournal of Neuro-Oncology, 2018
- Endoscopic Endonasal versus Microsurgical Transsphenoidal Approach for Growth Hormone–Secreting Pituitary Adenomas—Systematic Review and Meta-AnalysisWorld Neurosurgery, 2017
- Inception of a national multidisciplinary registry for stereotactic radiosurgeryJournal of Neurosurgery, 2016
- Adverse events associated with somatostatin analogs in acromegalyExpert Opinion on Drug Safety, 2015
- Acromegaly: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2014
- Fractionated stereotactic radiosurgery using the Novalis system for the management of pituitary adenomas close to the optic apparatusJournal of Clinical Neuroscience, 2014
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 UpdateEndocrine Practice, 2011
- Repeat Stereotactic Radiosurgery for Acoustic NeuromasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- AcromegalyEndocrinology and Metabolism Clinics of North America, 2008
- Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its errorJournal of Neurosurgery, 2006